The approval was based on data from the phase 3 TMB-302 trial that evaluated Trogarzo 800mg administered via IV push once every 2 weeks. The Food and Drug Administration (FDA) has approved Trogarzo ® ...

More than 2 weeks of treatment with cefepime administered by intravenous (IV) push significantly increases the risk of cefepime-induced neutropenia. A new study has demonstrated that prolonged courses ...

The Food and Drug Administration (FDA) has approved the HIV-1 medication ibalizumab-uiyk (Trogarzo, Theratechnologies Inc) for administration by intravenous push. Ibalizumab-uiyk, a long-acting ...

Can an amiodarone drip be converted to twice-daily IV bolus dosing if the patient is unable to take anything by mouth or nasogastric tube? In conclusion, on the basis of the pharmacokinetic properties ...

Claire Lang-Ree was in a lab coat taking a college chemistry class remotely in the kitchen of her Colorado Springs, Colo., home when a profound pain twisted into her lower abdomen. She called her mom, ...

Hospitals and health systems nationwide are implementing conservation strategies and exploring alternatives to address the national shortage of IV fluids. Hurricane Helene significantly damaged a ...